Abstract
Inspecting interactive behaviors of proteins in cancer cells and comparing them with those in normal cells to obtain cancer-perturbed protein network can shed light on how a normal cell transforms into a cancer cell. Rough protein–protein interaction networks of apoptosis in cancer and normal cells are constructed according to human yeast-two-hybrid data sets and websites. The nonlinear stochastic model, maximum likelihood parameter estimation, and Akaike Information Criteria (AIC) are employed to reduce high false-positive rates in these large-scale interactome. By comparing protein–protein interaction networks of apoptosis between HeLa cancer cells and normal cells, we obtain cancer-perturbed networks and gain insight into the mechanism of apoptotic network in human cancer, which helps discovery of cancer drug targets. This proposed method could be extended to construct other perturbed protein interaction networks of cancer cells such as perturbated protein interaction network of cell cycle.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Adams JM, Cory S (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26(9):1324–1337
Alon U (2007) An introduction to systems biology: design principles of biological circuits. Chapman & Hall/CRC, Boca Raton, FL
Andersen MH, Becker JC et al (2005) Regulators of apoptosis: suitable targets for immune therapy of cancer. Nat Rev Drug Discov 4(5):399–409
Araujo RP, Liotta LA et al (2007) Proteins, drug targets and the mechanisms they control: the simple truth about complex networks. Nat Rev Drug Discov 6(11):871–880
Bader GD, Betel D et al (2003) BIND: the Biomolecular Interaction Network Database. Nucleic Acids Res 31(1):248–2450
Bader JS, Chaudhuri A et al (2004) Gaining confidence in high-throughput protein interaction networks. Nat Biotechnol 22(1):78–85
Basu A (2003) Involvement of protein kinase C-delta in DNA damage-induced apoptosis. J Cell Mol Med 7(4):341–350
Carter GW (2005) Inferring network interactions within a cell. Brief Bioinform 6(4): 380–389
Chang YH, Wang YC et al (2006) Identification of transcription factor cooperativity via stochastic system model. Bioinformatics 22(18):2276–2282
Chen BS, Chang CH et al (2008a) Robust model matching control of immune systems under environmental disturbances: dynamic game approach. J Theor Biol 253(4):824–837
Chen BS, Chang YT (2008) A systematic molecular circuit design method for gene networks under biochemical time delays and molecular noises. BMC Syst Biol 2:103
Chen BS, Li CH (2007) Analysing microarray data in drug discovery using systems biology. Exper Opin Drug Discov 2(5):755–768
Chen BS, Wang YC (2006) On the attenuation and amplification of molecular noise in genetic regulatory networks. BMC Bioinform 7:52
Chen BS, Yang SK et al (2008b) A systems biology approach to construct the gene regulatory network of systemic inflammation via microarray and databases mining. BMC Med Genomics 1:46
Chen HC, Lee HC et al (2004) Quantitative characterization of the transcriptional regulatory network in the yeast cell cycle. Bioinformatics 20(12):1914–1927
Chu LH, Chen BS (2008a) Comparisons of Robustness and Sensitivity between Cancer and Normal Cells by Microarray Data. Cancer Inform 6:165–181
Chu LH, Chen BS (2008b) Construction of a cancer-perturbed protein-protein interaction network for discovery of apoptosis drug targets. BMC Syst Biol 2:56
Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2(9):647–656
Cusick ME, Klitgord N et al (2005) Interactome: gateway into systems biology. Hum Mol Genet 14 Spec No. 2:R171–181
Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116(2):205–219
Fesik SW (2005) Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 5(11):876–885
Gandhi TK, Zhong J et al (2006) Analysis of the human protein interactome and comparison with yeast, worm and fly interaction datasets. Nat Genet 38(3):285–293
Garber K (2005) New apoptosis drugs face critical test. Nat Biotechnol 23(4):409–411
Ghobrial IM, Witzig TE et al (2005) Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55(3):178–194
Gomez SM, Choi K et al (2008) Prediction of protein-protein interaction networks. Curr Protoc Bioinform Chapter 8:Unit 8 2
Hanash S (2004) Integrated global profiling of cancer. Nat Rev Cancer 4(8):638–644
He X, Zhang J (2006) Why do hubs tend to be essential in protein networks? PLoS Genet 2(6):e88
Hermjakob H, Montecchi-Palazzi L et al (2004) IntAct: an open source molecular interaction database. Nucleic Acids Res 32(Database issue):D452–455
Herr I, Debatin KM (2001) Cellular stress response and apoptosis in cancer therapy. Blood 98(9):2603–2614
Hood L (2003) Systems biology: integrating technology, biology, and computation. Mech Ageing Dev 124(1):9–16
Hood L, Heath JR et al (2004) Systems biology and new technologies enable predictive and preventative medicine. Science 306(5696):640–643
Hood L, Perlmutter RM (2004). The impact of systems approaches on biological problems in drug discovery. Nat Biotechnol 22(10):1215–1217
Johansson R (1993) System modeling and identification. Englewood Cliffs, NJ, Prentice Hall
Kaufmann T, Tai L et al (2007) The BH3-only protein bid is dispensable for DNA damage- and replicative stress-induced apoptosis or cell-cycle arrest. Cell 129(2):423–433
Klipp E, Herwig R, Kowald A, Wierling C, Lehrach H (2005) Systems biology in practice. Concepts, implementation and application. Wiley-VCH, Berlin
Lewin, B (2004) Genes VIII. Upper Saddle River, NJ, Pearson Prentice Hall
Lin LH, Lee HC et al (2005) Dynamic modeling of cis-regulatory circuits and gene expression prediction via cross-gene identification. BMC Bioinform 6:258
Markowetz F, Spang R (2007) Inferring cellular networks–a review. BMC Bioinform 8(Suppl 6):S5
Morris DS, Tomlins SA et al (2007) Integrating biomedical knowledge to model pathways of prostate cancer progression. Cell Cycle 6(10):1177–1787
Murray JI, Whitfield ML et al (2004) Diverse and specific gene expression responses to stresses in cultured human cells. Mol Biol Cell 15(5):2361–2374
Oltersdorf T, Elmore SW et al (2005) An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435(7042):677–681
Pelengaris S, Khan M et al (2002) c-MYC: more than just a matter of life and death. Nat Rev Cancer 2(10):764–776
Peri S, Navarro JD et al (2003) Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res 13(10):2363–2371
Rhodes DR, Chinnaiyan AM (2005) Integrative analysis of the cancer transcriptome. Nat Genet 37(Suppl):S31–37
Rhodes DR, Yu J et al (2004) Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 101(25):9309–9314
Riedl SJ, Salvesen GS (2007) The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 8(5):405–413
Riedl SJ, Shi Y (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5(11):897–907
Rual JF, Venkatesan K et al (2005) Towards a proteome-scale map of the human protein-protein interaction network. Nature 437(7062):1173–1178
Schrattenholz A, Soskic V (2008) What does systems biology mean for drug development? Curr Med Chem 15(15):1520–1528
Sebolt-Leopold JS, Herrera R (2004) Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 4(12):937–947
Sherr CJ, McCormick F (2002) The RB and p53 pathways in cancer. Cancer Cell 2(2):103–12
Stelzl U, Worm U et al (2005) A human protein-protein interaction network: a resource for annotating the proteome. Cell 122(6):957–968
Tao Y, Pinzi V et al (2007) Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway–therapeutic perspectives in cancer. Nat Clin Pract Oncol 4(10):591–602
Troyanskaya OG (2005) Putting microarrays in a context: integrated analysis of diverse biological data. Brief Bioinform 6(1):34–43
Vousden KH, Lane DP (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8(4): 275–283
Wada T, Penninger JM (2004) Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23(16):2838–2849
Weston AD, Hood L (2004) Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J Proteome Res 3(2):179–96
Youle RJ, Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9(1):47–59
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Chu, LH., Chen, BS. (2010). Construction of Cancer-Perturbed Protein–Protein Interaction Network of Apoptosis for Drug Target Discovery. In: Choi, S. (eds) Systems Biology for Signaling Networks. Systems Biology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-5797-9_24
Download citation
DOI: https://doi.org/10.1007/978-1-4419-5797-9_24
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-5796-2
Online ISBN: 978-1-4419-5797-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)